Gary Taylor

Stock Analyst at TD Cowen

(2.00)
# 3,117
Out of 5,090 analysts
148
Total ratings
50.51%
Success rate
-0.28%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $15.47
Upside: +61.60%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $18.83
Upside: +123.05%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $5.24
Upside: +138.55%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.65
Upside: +206.65%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $257.85
Upside: +3.94%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $19.55
Upside: -33.50%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $486.70
Upside: -9.60%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $330.91
Upside: +84.04%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $38.34
Upside: +132.13%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $151.86
Upside: +148.91%
Maintains: Hold
Price Target: $183$220
Current: $231.08
Upside: -4.79%
Maintains: Hold
Price Target: $139$150
Current: $117.39
Upside: +27.78%
Maintains: Outperform
Price Target: $30$26
Current: $23.84
Upside: +9.06%
Upgrades: Outperform
Price Target: $39$35
Current: $17.19
Upside: +103.61%
Maintains: Outperform
Price Target: $564$585
Current: $330.75
Upside: +76.87%
Maintains: Market Perform
Price Target: $3$6
Current: $16.77
Upside: -64.22%
Maintains: Outperform
Price Target: $10$8
Current: $6.48
Upside: +23.46%
Upgrades: Outperform
Price Target: $242$329
Current: $265.44
Upside: +23.95%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.58
Upside: +16.28%
Initiates: Market Perform
Price Target: $17
Current: $5.03
Upside: +237.97%
Downgrades: Underweight
Price Target: $28$20
Current: $210.00
Upside: -90.48%
Maintains: Neutral
Price Target: $33$20
Current: $22.12
Upside: -9.58%
Downgrades: Underweight
Price Target: n/a
Current: $3.57
Upside: -